Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory-Reference-Cited by-同舟云学术

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory

Published:2022-03 Issue: Volume:24 Page:43-58
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Veinalde Rūta,Pidelaserra-Martí Gemma,Moulin Coline^ORCID,Jeworowski Lara M.,Küther Linda,Buchholz Christian J.,Jäger Dirk,Ungerechts Guy,Engeland Christine E.^ORCID

Funder

Wilhelm Sander-Stiftung

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference62 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

2. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

3. The diverse functions of the PD1 inhibitory pathway;Sharpe;Nat. Rev. Immunol.,2018

4. PD-1 and PD-1 ligands: from discovery to clinical application;Okazaki;Int. Immunol.,2007

5. Current issues and perspectives in PD-1 blockade cancer immunotherapy;Chamoto;Int. J. Clin. Oncol.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer;Pharmaceutics;2024-09-07

2. Oncolytic viruses facilitate tumor immunotherapy;SCIENTIA SINICA Vitae;2024-09-01

3. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024

4. Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple;Cancers;2023-08-19

5. Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents;Cancer Immunology, Immunotherapy;2023-06-13